Form 8-K - Current report:
SEC Accession No. 0001213900-20-030802
Filing Date
2020-10-09
Accepted
2020-10-09 16:14:32
Documents
2
Period of Report
2020-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea128020-8k_citiuspharma.htm 8-K 37866
2 PRESS RELEASE DATED OCTOBER 7, 2020 ea128020ex99-1_citiuspharma.htm EX-99.1 22831
  Complete submission text file 0001213900-20-030802.txt   62015
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 201233349
SIC: 2834 Pharmaceutical Preparations